Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Latest news/
      3. Innovation/
      4. Meet 3 men who’ve been on the front lines of HIV treatments for decades
      Left to right: Joss J. De Wet, M.D., Johnson & Johnson's Brian Woodfall, M.D., and artist Tiko Kerr
      Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative
      Innovation

      Meet 3 men who’ve been on the front lines of HIV treatments for decades

      Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.

      Written by Johnson & Johnson
       | July 28, 2022
      July 28, 2022
      Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative
      hqdefault.jpg

      Johnson & Johnson J&J Innovative Medicine HIV/AIDS

      We’re committed to helping lead the fight against HIV/AIDS

      Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
      Learn more
      CTA-Red ribbon HIV

      More from Johnson & Johnson

      A visual representation connected to IBD treatment advancements in 2025, emphasizing innovation and progress in therapies for inflammatory bowel disease
      Innovation
      March 10, 2025

      Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

      Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
      Read more
      Illustration of innovative autoimmune disease treatment using monoclonal antibodies, advancing immune system research
      Innovation
      March 3, 2025

      The future of immunology

      Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
      Read more
      An image of colorectal cancer (left) and colitis (right), which can raise your risk of developing colorectal cancer
      Health & wellness
      February 27, 2025

      5 things we now know about colorectal cancer

      Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.
      Read more